Navigation Links
First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary
Date:1/6/2009

LAWRENCE, Mass., Jan. 6 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their five-year anniversary of home hemodialysis treatment with the NxStage(R) System One(TM), the first truly portable home hemodialysis machine. Each of the four patients touts an improved quality of life characterized by better health and well being.

As early adopters of daily home hemodialysis with the NxStage System One, each of the patients arrived at the decision to try NxStage at various stages in their treatment. All four patients are followed by Satellite WellBound Centers, a NxStage partner that established the first program in NxStage's IDE clinical study in 2003. These patients--Craig, Everett, Carl and Susan--began training with the NxStage System One on December 8th of 2003.

Carl emphasizes the significant health benefits of home hemodialysis

For Carl, who was diagnosed with kidney failure in 1996, in-center dialysis had been a physically grueling as well as intensely time-consuming process. "After starting on NxStage, I felt like a new person compared to when I was doing in-center hemo," stated Carl. Five years later, Carl is still feeling well and enjoying the benefits of daily home hemodialysis with the NxStage System One.

Everett knew there had to be a better way

Following two failed kidney transplants, Everett relied upon in-center dialysis treatments that lasted anywhere from two to three and a half hours. Then he learned about a new treatment based on a portable hemodialysis machine. Five years later, Everett does his hemodialysis at home six times a week. "I work treatments into my life, not the other way around," he insists. He's gone back to playing basketball, a sport he always loved but hadn't played in years due to fatigue.

Craig has taken his dialysis on the road

Craig has been dialysis-dependent since he was 19. When he heard about a new portable dialysis therapy that would enable him to do his treatments at home on a more frequent basis, Craig immediately knew the treatment option was for him. "I bugged my doctor for a year, incessantly, until it was available," he says. In December 2003, he started training on NxStage. With the NxStage System One, Craig has been able to return to work part-time, exercise more often and pursue his passion of camping and traveling.

Susan felt NxStage "gave me my life back"

When Susan's kidneys failed, she was forced to quit her job and go on permanent disability. Moreover, the fatigue and pain that ensued from her in-center dialysis treatments were completely incapacitating. After only one treatment on the NxStage System One, she recognized a difference in the way she felt. Just short of four years into her treatment with NxStage, Susan received a kidney transplant. Susan credits NxStage with helping her body feel healthy enough to sustain a transplanted kidney.

"Our research and experience have shown that more frequent dialysis provides patients with improved health outcomes such as reduced hospitalizations and improved mortality rates," stated John Moran, MB, BS, FRACP, FASN, senior vice president of clinical affairs for Satellite Healthcare and WellBound. "Daily home dialysis with NxStage is a tremendous treatment option for patients, and one from which many more dialysis patients could benefit."

"NxStage's founding mission is to give patients access to a range of dialysis therapies via the System One that deliver health benefits and meaningfully improve their quality of life," stated Jeffrey H. Burbank, founder and CEO of NxStage Medical, Inc. "We look forward to expanding on the success of these patients to increase awareness and improve the quality of life for thousands of dialysis patients with our products."

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

The patient testimonials included in this release are examples of patient experiences on daily home hemodialysis with the NxStage System One. All patient experiences will vary, and there can be no assurance that all patients will experience these benefits. All hemodialysis involves some risk, and patients are encouraged to speak with their physicians to see if home dialysis with the NxStage System One is right for them.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to: market acceptance of the NxStage System One, the anticipated impact and results of daily hemodialysis, and other factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact:

    Kristen K. Sheppard, Esq
    VP, Investor Relations
    ksheppard@nxstage.com

    Jane Hauser
    Schwartz Communications
    nxstage@schwartz-pr.com
    781-684-0770


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Board-Certified Bariatric Surgeon, Trace Curry, MD Places First Next-Generation Ethicon Endo-Surgery REALIZE™ Adjustable Gastric Band-C in Ohio
2. Robbins & Myers Revises Schedule for Release of First Quarter Fiscal 2009 Financial Results
3. MD Goes HD: Phoenix Doctor Is First to Use New High-Definition Television Production Vehicle to Help Educate and Teach From the Operating Room.
4. First Nationwide Folic Acid Survey of Spanish-Speaking Women Finds Most Are Missing Benefits, March of Dimes Says
5. Central Control is First Louisiana-Based Organization to Deploy Voice-Assisted Care
6. Universal Music Enterprises (UMe) and Body By Jake Global Create the Worlds First Digital Fitness Music Label
7. Supple, Hi-Flex Cable from Cicoil Makes First Disposable Hearing Aid Possible
8. YWCA Survey Reveals Women Want a Modern First Lady
9. Singapore is First in Asia to Use Limb-lengthening Technology for Those Wanting to be Taller
10. Breathing life into injured lungs: World-first technique will expand lung donor organ pool
11. Doctors Describe First U.S. Face Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... ... December 09, 2016 , ... Mediaplanet today announces distribution of the latest ... readers to sign up as an organ donor for the 123,000 people in the ... organ donor can save up to 8 saves through organ donation and enhance many ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... ... 08, 2016 , ... The Florida Hospital Tampa Wound Healing ... Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute ... and facilities have earned this distinction. This is the second time the Florida ...
(Date:12/8/2016)... ... 2016 , ... ZyDoc , a New York-based medical ... Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” has ... usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ natural ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of ... offering. ... report forecasts the global optical transceiver market to grow at a ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the shipment of optical ...
(Date:12/9/2016)...  Harmar Mobility, LLC announced today that Steven E. Dawson has been ... of Directors. Photo - http://photos.prnewswire.com/prnh/20161209/447552 ... Harmar ... Mr. Dawson,s executive career includes leadership roles managing ... of industries. He brings to the company deep operational and leadership expertise, ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a ... to address severe, rare diseases, today announced that senior management will ... Success Healthcare Conference at the InterContinental Barclay Hotel in ... 4:20 p.m. ET. About aTyr Pharma ... aTyr Pharma is engaged ...
Breaking Medicine Technology: